Men with erectile dysfunction and low testosterone levels have an increased risk of dying from cardiovascular disease
Citation: Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction. Corona G, Monami M, Boddi V, et al. J Sex Med 2010;7(4 Pt 1):1557−1564.
A consecutive series of 1687 patients attending an andrology clinic for erectile dysfunction (ED) was followed for a mean of 4.3 ± 2.6 years to investigate whether low testosterone levels predict incident fatal or nonfatal major adverse cardiovascular events (MACE) in men with ED. Patients in this prospective cohort study were interviewed using the structured interview on erectile dysfunction (SIEDY) and the ANDROTEST structured interview to measure aspects of ED and hypogonadal-related symptoms. Total testosterone was evaluated at baseline and information on MACE was obtained from registry database records.1
What is known
There is an increasing body of evidence to indicate that ED may be an early surrogate marker of a number of disease states, such as hypertension, metabolic syndrome, diabetes mellitus, depression and coronary heart disease.2-6 This suggests that a referral for ED provides a good opportunity to screen for comorbidities. Hypogonadism is an accepted contributor to ED, and testosterone therapy has been shown to benefit sexual function and improve the efficacy of phosphodiesterase type 5 inhibitor therapy for ED.3,7,8 Recent European consensus guidelines recognize that men with total testosterone levels below 8 nmol/L will usually benefit from testosterone therapy; additional investigation is recommended for men with levels between 8 and 12 nmol/L.9 Although there are suggestions that testosterone is a protective factor against the development of atherosclerosis,10 there is very sparse data on the effects of low testosterone and the incidence of MACE, particularly in men with ED
This study is the first to investigate whether low testosterone levels in men with ED predicts incident fatal or nonfatal MACE.
What this study adds
The study provides evidence that low testosterone levels are associated with a significantly higher mortality from MACE in men with erectile dysfunction. The identification of low testosterone levels should therefore alert the clinician to the possibility of increased risk of dying from a cardiovascular event.
Dr Giovanni Corona from the University of Florence, who led the research team, said that, although the findings need to be confirmed by larger studies, “…this is the first time that low testosterone has been associated with higher death rates from heart disease in men with erectile dysfunction. Our work shows that screening for testosterone deficiency in men with erectile dysfunction may help clinicians identify those at higher risk from cardiovascular events. However, at the moment we can't say whether low testosterone levels are the cause or the consequence of this higher risk.” While screening the testosterone levels of men with ED may be a worthwhile way of identifying those at most risk from heart disease, the numbers affected will be small, and large-scale studies are needed to look at whether testosterone therapy in at-risk men can help prevent unnecessary deaths from cardiovascular disease.1
*8, 10.4 and 12 nmol/L = 230, 300 and 350 ng/dL, respectively.